课题基金 / 基金详情

Identification of intracellular factors involved with apoptosis induction by TGF-β family

Identification of intracellular factors involved with apoptosis induction by TGF-β family
TGF-β家族诱导细胞凋亡相关细胞内因子的鉴定
批准号:
15390621
负责人:
FUKUDA Jinichi
金额:
$8.77万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

FUKUDA Jinichi的其他基金

相似基金

相关文献

中文摘要
翻译
TGF-β超家族成员参与多种生命现象的调节,包括初始发育、器官形成和肿瘤形成。我们发现激活素A和BMP-2抑制了B细胞杂交瘤HS-72的细胞生长,并研究了其细胞内转导机制。本研究以HS-72细胞、LS-1细胞和LS-12细胞为研究对象,通过流式细胞术分析激活素A对不同细胞的敏感性差异,发现激活素A在5-50 ng/ml浓度范围内可诱导HS-72细胞的细胞毒作用,并诱导细胞周期发生G1期阻滞和凋亡。结果表明,维甲酸对HS-72细胞毒性较小,细胞周期阻滞于G1期,而维甲酸与激活素A共刺激则能有效地诱导细胞周期阻滞于G1期,诱导细胞凋亡。激活素A和维甲酸对LS-1细胞无明显影响,但二者联合作用可使LS-1细胞发生G1期阻滞,亚G1期细胞比例增加。LS-12对活化素A和/或视黄酸呈中间型,提示活化素A和视黄酸之间的交联在诱导B系细胞凋亡中起重要作用。
英文摘要
Members of TGF-β superfamily are implicated in regulation of various life phenomenons, including initial development, organ formations and tumor formation. We found that activin A and BMP-2 inhibited cell growth of B cell hybridoma, HS-72 and examined its intracellular transduction mechanism. In the present study, we used three kinds of cells (HS-72 cells, LS-1 cells, and LS-12 cells) and investigated difference of sensitivity for activin A to these cells by flow cytometric analysis.We reported that activin A induced cytotoxic effects to HS-72, and induced G1 arrest in cell cycle and apoptosis at the concentration of 5-50 ng/ml. We clearly that retinoic acid induced a littel cytotoxity to HS-72 and G1 arrest in cell cycle, and that co-stimulation of retinoic acid and activin A potently induced G1 arrest and apoptosis. Activin A or retinoic acid have no effect to LS-1, however, co-stiluration of these factors induced G1 arrest and inclease of sub G1 rate of LS-1 cells. LS-12 showed intermediate type to Activin A and/or retinoic acid.Taken together, the results obtained in this study suggest that cross-talks between activin A and retinoic acid play an important role of the inductin of apoptosis in B lineage cells.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2004
期刊: Infect. Immun 72
影响因子: --
作者: [SUZUki, T.et al.]
通讯作者: T.et al.
Yoshinouchi et al.: "In vitro and in vivo growth supprcssion of human papillomavirus 16-positive cervical cancer cells by E6 siRNA"Molecular Therapy. 8. 762-768 (2003)
Yoshinouchi 等人:“E6 siRNA 对人乳头瘤病毒 16 阳性宫颈癌细胞的体外和体内生长抑制”分子疗法。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间: 2004
期刊: Infect.Immun 72
影响因子: --
作者: [Suzuki, T. et al.]
通讯作者: T. et al.
Growth/differentiation factor-S induces growth arrest and apoptosis in mouse B lineage cells with modulation by Smad
生长/分化因子-S 通过 Smad 调节诱导小鼠 B 谱系细胞生长停滞和凋亡
DOI: --
发表时间: 2003
期刊: Cell Signal 15
影响因子: --
作者: [Nakahara, T.et al.]
通讯作者: T.et al.
共 10 条
    Development of new anticancer drugs and nanobubbles suitable for specific molecular target therapy using sonoporation
    • 批准号:
      22390389
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2010
    • 负责人:
      FUKUDA Jinichi
    • 依托单位:
    Fas antigen and Fas ligand with Oral Disease
    • 批准号:
      10671900
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1998
    • 负责人:
      FUKUDA Jinichi
    • 依托单位:
    Expression and function of Fas antigen in human oral epithelium.
    • 批准号:
      08672324
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.22万
    • 财政年份:
      1996
    • 负责人:
      FUKUDA Jinichi
    • 依托单位:
    国内基金
    海外基金
    续骨活血汤通过TGF-β/MAPK轴调控BMP-2基因修饰BMSCs成骨分化联合3D打印复合陶瓷支架促进大段骨缺损修复的作用机制
    • 批准号:
      QN25H270007
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      王拓
    • 依托单位:
    丝素蛋白/BMP-2同轴静电纺丝纳米纤维复合磷酸镁骨水泥的仿生构建及其时空控释成骨机制研究
    CPC联合BMP-2过表达BMMSCs通过调控线粒体tRNA甲基化修饰促进成骨分化在骨缺损修复的机制及应用研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李广军
    • 依托单位:
    BMP-2、TGF-β2联合基因转染促进异体骨移植愈合的实验研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      周朝
    • 依托单位: